Highly malignant glioblastoma multiforme is divided into 3 subgroups according to the WHO classification (2016): IDH wild-type GBM (including giant cell GBM, gliosarcoma, and epithelioid GBM), IDH-mutant GBM, and GBM-NOS [2]. This evidence concerns the gene IDH1 and glioblastoma.